We also observed enhanced phosphorylation of ERK1/2 and NF-κB p65 subunit following CLIC1 overexpression (Fig. 4B), the activation of which has been shown to enhance motility in a range of cancers (20, 21). Here, MAPK3 is linked to cancer.